Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 6, 2021
Patent Application Number
16066187
Date Filed
December 21, 2016
Patent Citations
Patent Primary Examiner
Patent abstract
The present invention provides, among other things, compositions and methods for CNS delivery of Idursulfase-beta, a human recombinant iduronate-2-sulfatase protein, for effective treatment of Hunter Syndrome. The compositions and methods provided by the present invention effectively reduce symptoms not only in brain and spinal cord but also in peripheral tissues including heart, liver, spleen, lung, and kidney.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
